Clinical trial
Efficacy of Percutaneous Electrical Neurostimulation (PENS)of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix
NCT05742711 is registered in ClinicalTrials.gov with DyAnsys, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Percutaneous Electrical Neurostimulation (PENS)of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix
- Lead sponsor
- DyAnsys, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 16, 2023
- Completion date
- January 13, 2025
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of cervix, cancer of endometrium